- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Asahi Kasei wraps years of global dealmaking into a single brand | ||
| 30.09. | Varda brings home $251M series D to fuel space-based drug manufacturing | ||
| 30.09. | Vanda lines up new expansion prospect for Hetlioz as FDA jet lag hearing looms | ||
| 30.09. | Hansoh's Tagrisso rival loses EU approval after AstraZeneca legal challenge | ||
| 30.09. | CSL Seqirus boasts bigger batch of flu vaccines ahead of US flu season | ||
| 30.09. | Alnylam drafts football veteran Pete Shaw for heart disease education push | ||
| 29.09. | NorthStar locks down $185M as radiopharmaceutical isotope, CDMO expansion plans advance | ||
| 29.09. | PhRMA locks in former House Majority Leader Cantor as next CEO | ||
| 29.09. | White House lays groundwork to reshore production of 86 essential medicines | ||
| 29.09. | Big Pharma's Big Brand: Regeneron's science-driven communications approach | ||
| 29.09. | Novo, Lilly pit their GLP-1s against one another in diabetes and obesity as EASD kicks off in Milan | ||
| 29.09. | US details rules for 0% specialty pharmaceutical tariff exemptions | ||
| 29.09. | Inizio Evoke names new leaders in media, AI and client accounts | ||
| 29.09. | Audien beams up William Shatner to boldly boost OTC hearing aid awareness | ||
| 29.09. | AstraZeneca scales Summit's PD-1xVEGF strategy with $2B investment to fuel ADC combos | ||
| 28.09. | BioNTech to close 3 sites in Germany after failed buyer search | ||
| 28.09. | Roche's Gazyva secures FDA nod for idiopathic nephrotic syndrome, extending autoimmune pivot | ||
| 28.09. | Eli Lilly's new initiative will take GLP-1s to lower-income nations | ||
| 25.09. | Merck's holistic HIV health hive buzzes with the help of actress Debbie Allen | ||
| 25.09. | AbbVie's Cerevel buyout delivers as FDA gives go-ahead to 1st-in-class Juvmo in Parkinson's disease | ||
| 25.09. | Merck, Eisai's Welireg-Lenvima combo lands FDA nod to jump the kidney cancer queue | ||
| 25.09. | Lundbeck to move US digs to Boston as it eyes bigger innovation frontiers | ||
| 25.09. | Fierce Pharma Week: A look at the biggest trends, campaigns and conversations | ||
| 25.09. | Fierce Pharma Asia-Lilly's $3.35B InnoCare deal; Korea's breakthrough; China's 5-year biotech plan | ||
| 25.09. | Eli Lilly blasted for 'promotional and emotive' language in GLP-1 press release |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.